Biotech: Page
-
PharmaVoice Team/PharmaVoice
Medicare Part D: A Whole New Market
Medicare Part D: A Whole New Market By Kim Ribbink Marketers, manufacturers, health plans, and other stakeholders who will play a central role in the Medicare Modernization Act (MMA) are gearing up for implementation. And while there is widespread support for a change that will improve coverage t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Perspective
Is Japan on the Verge of a Biotech Boom? A growing number of biopharma start-up companies are looking beyond the United States and Europe for business opportunities. And one market that is generating a lot of buzz in biotech today is Japan. One of the more under-reported business stories of the p...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineTech for Clinical Trials
Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Solutions From PHT Provide Clinical Trial Savings and Flexibility Two recently launched offerings from PHT Corp., LogPad Phone and the Technology Transfer Program, aim to make the electronic capture of clinical-trial information e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Prioritizing the Pipeline: The Critical Role of Porfolio Management
Prioritizing the Pipeline The critical role of portfolio management Increased pressures on the pharmaceutical industry – shrinking pipelines, rising costs, reimbursement issues, regulatory pressures, and consumer demands – mean companies have to find ways to focus on the projects that will meet c...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Value of Phase IV
BY Elisabeth Pena The Value of Phase IV Postmarketing research can be crucial for tracking side effects and exploring new uses for an approved drug. But these trials are heavily scrutinized because some say pharma companies have conducted such studies purely for promotional purposes with little s...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry Pharma POOL Robert Boisclair Dr. Richard Bowles Steve Chellevold Mary-Frances Faraji Brent Saunders Schering-Plough Announces Senior-Level Management Changes Schering-Plough, Kenilworth, N.J., has made senior-level management change...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry Profitable Biotech Companies Predicted to double in Next Few Years Therapeutic proteins and therapeutic antibodies collectively comprise almost 75% of biotech drugs currently on the market. Protein drugs also represent one of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
talent pool executive appointments and promotions in the healthcare industry Pharma POOL Robert Bertolini Schering-Plough Appoints Executive VP, Chief Financial Officer Schering-Plough has appointed Robert J. Bertolini as executive VP and chief financial officer. He also serves on the Schering-Pl...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies RxPedite Established to Provide Solutions to Emerging pharma and Biotech Companies Cardinal Health and inChord joint venture offers a full range of of launch-support services. RxPedite LLC has been established to provide comprehe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dr. Victoria Hale: Hale to a Champion
Hale to a champion By Kim Ribbink Dr. Victoria Hale, who both conceptualized and founded a nonprofit pharmaceutical company, is a true pioneer. Her goal is to create affordable, safe, and efficacious treatments for infectious diseases that affect millions in developing nations. Already, her compa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
ROI on the Internet
By Elisabeth Pena ROI Return on the Internet The ability for pharma marketers to track online consumers’ reactions to Internet advertising is limited, but as the medium matures, tools are evolving to make it easier to measure return on investment. John Racik The days of click-throughs and banner ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating Effective Outsourcing Partnerships
Creating Effective Outsourcing Partnerships By Denise Myshko Pharmaceutical companies are adopting a more strategic approach to outsourcing clinical-research services. Contract research outsourcing has grown exponentially over the past 30 years. In the 1970s, outsourcing was limited to preclinica...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry World Pharma Market Continues to Grow Amid Shifting Trends and Emerging Markets Though the pharmaceutical industry remains one of the most profitable and stable industries, several broad variables are leading to fu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies Brand Institute Establishes New Subsidiary to Minimize Medication Errors The FDA’s Jerry Phillips joins private sector to continue risk-management work. Brand Institute has launched a new subsidiary – Drug Safety Institute (DSI) ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Obesity: A Market in Need of a Solution
Obesity A Market in Need of a Solution By Denise Myshko with a potentially open market for drugs to treat obesity and related diseases, pharmaceutical companies not only have to provide a pharmacological solution but also address the life-style issues associated with the disease and develop safe ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
CNS: A Complex Therapeutic and Patient-Recruitment Market
CNS By Lisa Dress A Complex Therapeutic and Patient-Recruitment Market An explosion of new science is leading to potential compounds to treat CNS diseases. The challenge for pharmaceutical companies and their partners is recruiting and retaining patients for trials. Understanding the brain and ho...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Coaching: Developing a Playbook for Sales Rep Success
pharmaceutical sales managers need to be taught how to hone their own coaching and counseling skills, as well as have a clear corporate direction to understand what is required from their people. An array of tools exist to help them to improve performance. Given the right coaching, the coach or m...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The State of CME: Light at the End of the Tunnel
The State of CME light at the end of the tunnel BY ELISABETH PENA Conservatism has marked the pharmaceutical industry’s approach to CME following last year’s release of OIG guidelines, which suggest that manufacturers should take the programs out from under marketing and sales. The industry waits...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Ian McInnes Dr. Cecil B. Pickett Schering-Plough Announces Executive Appointments Schering-Plough, Kenilworth, N.J., a research-based company engaged in the discovery, development, manufacturing, and mark...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Getting Into the Details of E-Detailing
Getting into the details of e-detailing BY DENISE MYSHKO E-detailing is slowly becoming an accepted medium for bringing new information to physicians. As part of an overall integrated e-communications strategy, e-detailing holds the promise for building better relationships with prescribers and o...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managing Outcomes
Managing Outcomes BY ELISABETH PENA Limits on reimbursement for prescription drugs are expected to have a long-term impact on drug development. to address payer concerns, companies will need to have data on cost versus utility, and those data come from outcomes studies. But if they are to use suc...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Trials Around the World
Trials Around the World By Denise Myshko Many pharmaceutical companies and CROs are tapping Eastern Europe, Asia, Latin America, and other areas to meet their clinical-trial needs. While there are challenges associated with conducting research in nontraditional geographic regions – such as nascen...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Improving Advocacy Relations
Improving Advocacy relations By Elisabeth Pena By forming relationships with advocacy organizations, pharmaceutical companies can better serve their target patient populations, which in turn will give them allies in the court of public opinion. P harmaceutical companies are in the middle of a pub...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions in the Healthcare Industry Featured Talent: Pharma POOL Joy A. Amundson, Baxter International Bruce McGillivray, Baxter International Jim Utts, Baxter International Brian Crombie , Biovail David Keefer, Biovail Charles Rowland, Biovail Paul Duffy, Ala...
By PharmaVoice Team • Jan. 2, 2008
Previous
